Allergan Aesthetics moves to acquire Cypris Medical, develop Xact device

Allergan Aesthetics has entered into an option to acquire Cypris Medical, according to a press release.

Under the warrant agreement, Allergan, an AbbVie company, will have the right to acquire the Chicago-based medical device company, including its Xact device, after a clinical trial of the device.

Xact is a tool designed to replace the scalpel in face and neck lifts, allowing for lifting and suturing of the superficial muscular aponeurotic system.

“As a global leader in aesthetics, we are proud to support the research of an innovative device that complements our iconic portfolio of noninvasive treatment options like Botox Cosmetic and our Juvéderm collection of fillers,” Carrie Strom, senior vice president AbbVie and president, Global Allergan Aesthetics, said in the release. “We know there is continued unmet need for minimally invasive procedures for midface descent, and Xact affords us the ability to create a new alternative for our customers so they can continue to offer leading-edge treatments to patients.”